2025-10-24 - Analysis Report
Okay, here's an analysis of First Solar Inc. (FSLR) based on the provided information.

## FSLR Analysis

**0) Report Summary**

This report analyzes First Solar Inc. (FSLR), focusing on its stock performance, financial health, recent news, and analyst ratings. It compares FSLR's returns to the S&P 500 (VOO), examines key technical indicators, reviews recent earnings, and analyzes revenue, profitability, equity, and ROE.

**1) Stock Performance vs. S&P 500 (VOO)**

*   **Ticker:** FSLR
*   **Company:** First Solar Inc. (A leading manufacturer of solar panels and provider of comprehensive PV system solutions.)
*   **FSLR Cumulative Return:** 63.29%
*   **VOO Cumulative Return:** 99.09%
*   **Absolute Divergence:** -28.7 (FSLR underperformed VOO)
*   **Relative Divergence:** 23.7 (FSLR's relative divergence indicates its position within its historical performance range compared to VOO, suggesting it is currently in the lower quartile.)

    **Analysis of Alpha/Beta Data Table:**

    | Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
    |------------|--------|--------|--------|-------|--------|
    | 2015-2017  | 33.0%  | 74.6%  | 5.0%   | -0.0  | 7.3    |
    | 2016-2018  | -23.0% | 73.2%  | -38.0%  | 0.0   | 4.6    |
    | 2017-2019  | 34.0%  | 73.2%  | 12.0%  | -0.2  | 6.1    |
    | 2018-2020  | 12.0%  | 81.0%  | -11.0%  | -0.3  | 10.7   |
    | 2019-2021  | 55.0%  | 81.0%  | 8.0%   | -0.9  | 9.4    |
    | 2020-2022  | 129.0% | 81.0%  | 130.0% | 0.3   | 16.2   |
    | 2021-2023  | 33.0%  | 80.7%  | 31.0%  | 1.9   | 18.6   |
    | 2022-2024  | 22.0%  | 84.0%  | 1.0%   | 1.6   | 19.1   |
    | 2023-2025  | -61.0% | 84.0%  | -124.0% | 5.3   | 24.6   |

    *   **CAGR:** Fluctuates significantly, with strong positive periods (2020-2022) followed by a sharp decline (2023-2025).
    *   **MDD:** Consistently high, indicating significant drawdowns.
    *   **Alpha:** Highly variable, suggesting periods of both significant outperformance and underperformance relative to the market. Recent alpha is very negative.
    *   **Beta:** Increasing over time, suggesting a growing correlation with the market. The high beta in the most recent period (5.3) suggests extreme sensitivity to market movements.
    *   **Cap(B):** Company capitalization has grown significantly, especially in recent years.

**2) Recent Stock Price Movement**

*   **Current Price:** $226.85
*   **Last Market Data:**
    *   Price: $229.0
    *   Previous Close: $223.36
    *   Change: $2.53
*   **Moving Averages:**
    *   5-day MA: $233.978
    *   20-day MA: $227.439
    *   60-day MA: $207.3693

    **Analysis:** The current price is below the 5-day moving average but above the 20-day and 60-day moving averages. The recent market data indicates a positive change of $2.53, reflecting a recent upward movement.

**3) Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 51.63 (Neutral)
*   **PPO:** -0.4755 (Slightly Bearish)
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)" This suggests a strong buy signal based on the MRI.
*   **Recent (20-day) Relative Divergence Change:** 0.6 (+) Indicates short-term upward trend.
*   **Expected Return:** 50.3% (Long-term projected outperformance vs. S&P 500 if investing regularly).
    *The recent market data indicates a positive change of $2.53, reflecting a rebound from previous dips, which potentially amplifies the bullish signals.*

**4) Recent News & Significant Events (Yahoo Finance):**

*   **Earnings Expectations:** Anticipated earnings growth ahead of next week's release.
*   **Price Target Adjustments:** Wolfe adjusted price target upwards to $232, maintaining an "Outperform" rating. RBC also raised its price target to $244, keeping an "Outperform" rating.
*   **Analyst Coverage:** Needham initiated coverage with a "Buy" rating and a $286 price target.
*   **Market Reaction:** FSLR dipped more than the broader market on one day.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.60 (~Buy)
*   **Number of Opinions:** 31
*   **Target Price:**
    *   Average: $242.25
    *   High: $300.00
    *   Low: $100.00
*   **Recent Rating Changes:** Not specified in provided data.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-07-31 | 3.19 | 1.10 B$    |
| 2025-04-29 | 1.96 | 0.84 B$    |
| 2024-10-29 | 2.92 | 0.89 B$    |
| 2024-07-30 | 3.26 | 1.01 B$    |
| 2025-07-31 | 3.26 | 1.01 B$    |

*   **Analysis:** The earnings data shows fluctuations in both EPS and revenue. The most recent EPS is $3.26, with revenue at $1.01B.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $1.10B    | 45.56%        |
| 2025-03-31   | $0.84B    | 40.78%        |
| 2024-12-31   | $1.51B    | 37.49%        |
| 2024-09-30   | $0.89B    | 50.17%        |
| 2024-06-30   | $1.01B    | 49.37%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-06-30   | $8.55B    | 4.00% |
| 2025-03-31   | $8.19B    | 2.56% |
| 2024-12-31   | $7.98B    | 4.93% |
| 2024-09-30   | $7.59B    | 4.12% |
| 2024-06-30   | $7.26B    | 4.82% |

*   **Analysis:** Revenue has fluctuated, with a high in Q4 2024. Profit margins are generally strong, ranging from 37.49% to 50.17%. Equity has consistently increased, and ROE has remained relatively stable.

**7) Overall Summary**

*   **Performance:** FSLR has underperformed the S&P 500 recently, but analysts remain bullish.
*   **Technicals:** Technical indicators provide a mixed picture, with the MRI strongly recommending investment but the PPO being slightly bearish.
*   **Recent News:** Positive news includes upward price target revisions and new analyst coverage with "Buy" ratings. However, there was also a day when FSLR dipped more than the broader market.
*   **Earnings & Financials:** Recent earnings show a rebound, and the company maintains strong profit margins and increasing equity.
*   **Analyst Consensus:** Strong "Buy" consensus with an average price target above the current price suggests further upside potential.

**Conclusion:**

FSLR presents a mixed picture. While it has underperformed the broader market recently, strong analyst ratings, positive earnings news, and a high MRI suggest potential for future growth. However, the high beta indicates it can be more volatile than the market. The recent rebound in price and positive change in market data further support a potential upward trend.

*Disclaimer: This analysis is based solely on the provided data and does not constitute financial advice. Investment decisions should be made after consulting with a qualified financial advisor.*
